Table 4.
Summary of results from the global glymphatic transport analysis
Age (wk) | Strain | N | K1 (ml · cm−3 · min−1) | k2 (min) | VECS (%) | VCSF (%) | Fit RMSE (mmol/cm3) |
---|---|---|---|---|---|---|---|
7–9 | WKY | 9 | 0.0069 ± 0.0017 | 0.0242 ± 0.006 | 29.5 ± 6.8 | 5.4 ± 2.1 | 0.0016 ± 0.0011 |
SHR | 6 | 0.0049 ± 0.0014**a | 0.0226 ± 0.007 | 22.0 ± 2.7*d | 4.0 ± 3.1 | 0.0012 ± 0.0005 | |
19–21 | WKY | 5 | 0.0058 ± 0.0008 | 0.0205 ± 0.002 | 28.5 ± 5.2 | 6.9 ± 2.2 | 0.0012 ± 0.0001 |
SHR | 7 | 0.0037 ± 0.0011*b | 0.0151 ± 0.004*c | 24.8 ± 4.9 | 4.4 ± 1.7 | 0.0011 ± 0.0001 |
*p < 0.05;
**p < 0.01; K1, k2; one-tailed Mann–Whitney U tests (SHR < WKY); VECS, VCSF: two-tailed Mann–Whitney U tests;
ap = 0.0088;
bp = 0.015;
cp = 0.036;
dp = 0.0027.